When should I get the flu shot? What experts say is the ideal time to protect yourself
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
29 trends tracked about this subject — the full history, oldest to newest below.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Health officials and outlets urge annual flu vaccinations as respiratory virus season arrives.
Respiratory virus season arrives early as coverage highlights rising flu cases alongside available vaccines for COVID-19 and RSV.
Winter flu and Covid-19 vaccinations have officially rolled out as health officials urge eligible groups to book jabs.
8 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent coverage highlights seasonal flu vaccination benefits for healthy aging, dementia risk reduction, and children's health.
The US has seen the launch of Moderna's mFlusiva, the first approved mRNA flu vaccine designed for specific older adult populations.
21 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
A newly approved mRNA flu shot for adults 50+ is rolling out at CVS, Walgreens and local pharmacies as the 2026 flu season approaches.
Health authorities in Illinois and across the West Coast are releasing updated 2026-27 respiratory virus vaccine guidance to address public confusion.
Media outlets and health experts urge early flu shot planning as the 2026-2027 season approaches.
The 2026–2027 COVID-19 vaccines have arrived alongside seasonal flu shots as infection rates climb across the United States.
Health coverage highlights FDA approval of Moderna's new mRNA flu vaccine and emerging studies on broader antibody responses.
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Leading US medical groups have issued independent vaccine guidance for the 2026-2027 respiratory season to address public confusion and regulatory gaps.
GSK advances its mRNA flu vaccine candidate to phase 3 trials following successful mid-stage performance data.
GSK is advancing a new mRNA flu vaccine to Phase III trials after the candidate outperformed standard vaccinations in earlier testing.
Public health concerns rise as media outlets and major pharmacies address the upcoming flu and COVID-19 season.
10 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
The FDA has approved Moderna's mRNA-based flu vaccine, marking a shift in immunization technology for older adults.
An mRNA flu shot becomes available in the United States for the first time, according to Smithsonian Magazine.
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
The first mRNA-based flu vaccine has been approved in the US, specifically targeting adults aged 50 and over for improved effectiveness.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
The U.S. has approved the first-ever mRNA flu vaccine from Moderna, though concerns over side effects may impact public adoption.
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
An FDA advisory committee has unanimously backed Moderna's mRNA-based flu vaccine, marking a significant development for the technology.